Designed specifically for big AI projects, Gefion - named after the Norse goddess of fertility - was funded to the tune of ...

Castlewood and Deuel square off in Class B high school softball battle during a triangular with Oldham-Ramona-Rutland ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

This article looks at the top three catalysts that will impact these ETFs like SPY, QQQ, and DIA later this week.

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

Innovative statistical method helps determine ideal threshold times in restricted mean survival time analyses.

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

We recently published a list of 10 Best Stocks to Invest in for Long Term. In this article, we are going to take a look at ...

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.